Epidemiology and burden of HPV-related disease
- PMID: 29037457
- DOI: 10.1016/j.bpobgyn.2017.08.006
Epidemiology and burden of HPV-related disease
Abstract
Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-related cancer in both men and women. High-risk HPV types are not only responsible for virtually all cervical cancer cases but also for a fraction of cancers of the vulva, vagina, penis, anus, and head and neck cancers. Furthermore, HPV is also the cause of anogenital warts and recurrent respiratory papillomatosis. Despite the availability of multiple preventative strategies, HPV-related cancer remains a leading cause of morbi-mortality in many parts of the world, particularly in less developed countries. Thus, in this review, we summarize the latest estimates of the global burden of HPV-related diseases, trends, the attributable fraction by HPV types, and the potential preventative fraction.
Keywords: Attributable fraction; Cancer; Human papillomavirus; Papillomavirus vaccines; Prevention; Time trends.
Copyright © 2017. Published by Elsevier Ltd.
Similar articles
-
Global burden of human papillomavirus and related diseases.Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Vaccine. 2012. PMID: 23199955 Review.
-
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.Int J Cancer. 2012 Nov 1;131(9):1969-82. doi: 10.1002/ijc.27650. Epub 2012 Jul 2. Int J Cancer. 2012. PMID: 22623137 Free PMC article. Review.
-
Global prevention and management of human papillomavirus related diseases: the pressing challenges and the compelling opportunities. Foreword.Vaccine. 2012 Nov 20;30 Suppl 5:vii-x. doi: 10.1016/j.vaccine.2012.07.071. Vaccine. 2012. PMID: 23199970 No abstract available.
-
Comprehensive control of human papillomavirus infections and related diseases.Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Vaccine. 2013. PMID: 24331745 Review.
-
Cancer incidence in Germany attributable to human papillomavirus in 2013.BMC Cancer. 2017 Oct 16;17(1):682. doi: 10.1186/s12885-017-3678-6. BMC Cancer. 2017. PMID: 29037233 Free PMC article.
Cited by
-
Research trends and hotspots on human papillomavirus: a bibliometric analysis of 100 most-cited articles.Ann Transl Med. 2022 Aug;10(15):816. doi: 10.21037/atm-22-463. Ann Transl Med. 2022. PMID: 36034987 Free PMC article.
-
Prevalence and Genotype Distribution of Human Papillomavirus Among Attendees at a Sexually Transmitted Diseases Clinic in Urban Tianjin, China.Int J Gen Med. 2021 May 20;14:1983-1990. doi: 10.2147/IJGM.S308215. eCollection 2021. Int J Gen Med. 2021. PMID: 34045890 Free PMC article.
-
Human Papillomavirus Vaccines: An Updated Review.Vaccines (Basel). 2020 Jul 16;8(3):391. doi: 10.3390/vaccines8030391. Vaccines (Basel). 2020. PMID: 32708759 Free PMC article. Review.
-
Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia.BMC Cancer. 2020 Oct 7;20(1):972. doi: 10.1186/s12885-020-07452-6. BMC Cancer. 2020. PMID: 33028248 Free PMC article.
-
Prevention and treatment of human papillomavirus in men benefits both men and women.Front Cell Infect Microbiol. 2022 Nov 24;12:1077651. doi: 10.3389/fcimb.2022.1077651. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36506029 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical